Hologic Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Steve MacMillan
Chief executive officer
US$15.6m
Total compensation
| CEO salary percentage | 7.6% |
| CEO tenure | 11yrs |
| CEO ownership | 1.0% |
| Management average tenure | 3.9yrs |
| Board average tenure | 7.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 28 2024 | n/a | n/a | US$790m |
| Jun 29 2024 | n/a | n/a | US$702m |
| Mar 30 2024 | n/a | n/a | US$467m |
| Dec 30 2023 | n/a | n/a | US$515m |
| Sep 30 2023 | US$16m | US$1m | US$456m |
| Jul 01 2023 | n/a | n/a | US$484m |
| Apr 01 2023 | n/a | n/a | US$753m |
| Dec 31 2022 | n/a | n/a | US$990m |
| Sep 24 2022 | US$14m | US$1m | US$1b |
| Jun 25 2022 | n/a | n/a | US$2b |
| Mar 26 2022 | n/a | n/a | US$2b |
| Dec 25 2021 | n/a | n/a | US$2b |
| Sep 25 2021 | US$15m | US$1m | US$2b |
| Jun 26 2021 | n/a | n/a | US$2b |
| Mar 27 2021 | n/a | n/a | US$2b |
| Dec 26 2020 | n/a | n/a | US$1b |
| Sep 26 2020 | US$14m | US$1m | US$1b |
| Jun 27 2020 | n/a | n/a | US$497m |
| Mar 28 2020 | n/a | n/a | US$453m |
| Dec 28 2019 | n/a | n/a | US$84m |
| Sep 28 2019 | US$12m | US$1m | -US$204m |
| Jun 29 2019 | n/a | n/a | -US$30m |
| Mar 30 2019 | n/a | n/a | -US$11m |
| Dec 29 2018 | n/a | n/a | -US$419m |
| Sep 29 2018 | US$42m | US$1m | -US$111m |
Compensation vs Market: Steve's total compensation ($USD15.56M) is above average for companies of similar size in the German market ($USD4.86M).
Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.
CEO
Steve MacMillan (60 yo)
11yrs
Tenure
US$15,555,032
Compensation
Mr. Stephen P. MacMillan, also known as Steve, serves as an Independent Chairman of the Board at Illumina, Inc. from June 02, 2023. He has been the Chairman of the Board at Hologic Inc. since June 17, 2015...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11yrs | US$15.56m | 1.05% € 163.5m | |
| Chief Financial Officer | 6.3yrs | US$3.93m | 0.045% € 7.0m | |
| Chief Operating Officer | less than a year | US$2.17m | 0.012% € 1.9m | |
| General Counsel | 9.8yrs | US$3.34m | 0.080% € 12.5m | |
| Group President of International | no data | US$3.52m | 0.046% € 7.1m | |
| Chief Information Officer | 3.4yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior Vice President of Global Human Resources | less than a year | no data | no data | |
| VP & Chief of Staff | 10.9yrs | no data | no data | |
| Division President of Breast & Skeletal Health Solutions | 4.3yrs | no data | 0.010% € 1.6m | |
| President of Diagnostics Solutions | 1.7yrs | no data | 0.0053% € 830.6k | |
| Senior Vice President of Global Supply Chain | 1.2yrs | no data | no data |
3.9yrs
Average Tenure
56yo
Average Age
Experienced Management: HO1's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11yrs | US$15.56m | 1.05% € 163.5m | |
| Independent Director | 11.6yrs | US$339.96k | 0.019% € 2.9m | |
| Independent Director | 17.2yrs | US$374.96k | 0.058% € 9.0m | |
| Director | no data | no data | no data | |
| Independent Director | 1.9yrs | US$338.44k | 0.000070% € 10.9k | |
| Independent Director | 6.1yrs | US$319.96k | 0.0026% € 400.5k | |
| Independent Director | 7.6yrs | US$344.96k | 0.0068% € 1.1m | |
| Independent Director | 13.1yrs | US$319.96k | 0.019% € 3.0m | |
| Lead Independent Director | 8yrs | US$319.96k | 0.0078% € 1.2m | |
| Independent Director | 1.3yrs | US$128.96k | 0.00033% € 51.4k |
7.8yrs
Average Tenure
62yo
Average Age
Experienced Board: HO1's board of directors are considered experienced (7.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 11:24 |
| End of Day Share Price | 2024/12/16 00:00 |
| Earnings | 2024/09/28 |
| Annual Earnings | 2024/09/28 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hologic, Inc. is covered by 51 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Charles Butler | Barclays |